TNBC
Clinical trials for TNBC explained in plain language.
Never miss a new study
Get alerted when new TNBC trials appear
Sign up with your email to follow new studies for TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to wipe out early triple-negative breast cancer before surgery
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug camrelizumab to chemotherapy and targeted radiation before surgery can eliminate all signs of cancer in women with early-stage triple-negative breast cancer. About 43 women will receive the combination for 12 weeks, then have…
Matched conditions: TNBC
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
Gut bacteria pill joins forces with chemo to fight aggressive breast cancer
Disease control Not yet recruitingThis study tests whether adding a live bacteria pill (MO-03) to standard chemotherapy and immunotherapy can improve outcomes for people with early-stage triple-negative breast cancer. About 50 participants will take the pill twice daily until surgery. The main goal is to see if t…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New drug combo targets tough breast cancer in early trial
Disease control Not yet recruitingThis study tests a combination of two drugs, inavolisib and eribulin, in people with advanced triple-negative breast cancer that has a specific genetic change (PIK3CA mutation) and has not responded to at least one prior treatment. The goal is to see if the combination shrinks tu…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Hu Hai • Aim: Disease control
Last updated May 18, 2026 12:04 UTC